116
Participants
Start Date
May 31, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
August 31, 2013
PEG-Tα1
1.6 mg/ml, once a week, taken subcutaneously
Placebo to match PEG-Tα1
1ml, once a week, taken subcutaneously
Adefovir
10 mg, once daily, taken orally for 48 weeks
302 Military Hoapital of China, Beijing
Hainan General Hospital, Haikou
The Third Hospital of Hebei Medical University, Shijiazhuang
The Second Xiangya Hospital of Central South University, Changsha
81 Military Hospital of China, Nanjing
Jiangsu Province Hospital, Nanjing
The Second Hospital of Nanjing, Nanjing
The First Hospital of Jilin University, Changchun
The Sixth People's Hospital of Shenyang, Shenyang
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an
West China Hospital Sichuan University, Chengdu
Lead Sponsor
Collaborators (1)
Nanjing Medical University
OTHER
Jiangsu Hansoh Pharmaceutical Co., Ltd.
INDUSTRY